Both in Pharmaceuticals
Olema Pharmaceuticals vs Immix Biopharma
Over the past year OLMA returned −10.5% and IMMX returned +406.7%; their daily moves had a correlation of 0.10.
OLMA −10.5% IMMX +406.7%Growth of $1, one year, split-adjusted
| Metric | OLMA | IMMX |
|---|---|---|
| Price | $8.54 | $10.54 |
| Market cap | $747.2M | $754.0M |
| Today | −0.81% | −8.11% |
| 1 month | −16.8% | −24.4% |
| 6 months | −36.4% | +22.8% |
| Year to date | −65.8% | +101.5% |
| 1 year | −10.2% | +406.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $458.1M | $232.1M |
| Dividend yield | — | — |
| Volatility (60d) | 52.8% | 83.7% |
| Short % of float | 27.8% | 20.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).